申请人:Liu Hong
公开号:US20090247517A1
公开(公告)日:2009-10-01
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1).
本发明提供了化合物、包含这些化合物的制药组合物以及使用这些化合物治疗或预防与大麻素受体1(CB1)的活性有关的疾病或紊乱的方法。